Literature DB >> 26948890

Cerebellar Transcriptome Profiles of ATXN1 Transgenic Mice Reveal SCA1 Disease Progression and Protection Pathways.

Melissa Ingram1,2, Emily A L Wozniak1,3, Christine Henzler4, Lisa Duvick1,5, Rendong Yang4, Paul Bergmann6, Robert Carson1,5, Brennon O'Callaghan1,5, Huda Y Zoghbi7, Harry T Orr1,5.   

Abstract

SCA1, a fatal neurodegenerative disorder, is caused by a CAG expansion encoding a polyglutamine stretch in the protein ATXN1. We used RNA sequencing to profile cerebellar gene expression in Pcp2-ATXN1[82Q] mice with ataxia and progressive pathology and Pcp2-ATXN1[30Q]D776 animals having ataxia in absence of Purkinje cell progressive pathology. Weighted Gene Coexpression Network Analysis of the cerebellar expression data revealed two gene networks that significantly correlated with disease and have an expression profile correlating with disease progression in ATXN1[82Q] Purkinje cells. The Magenta Module provides a signature of suppressed transcriptional programs reflecting disease progression in Purkinje cells, while the Lt Yellow Module reflects transcriptional programs activated in response to disease in Purkinje cells as well as other cerebellar cell types. Furthermore, we found that upregulation of cholecystokinin (Cck) and subsequent interaction with the Cck1 receptor likely underlies the lack of progressive Purkinje cell pathology in Pcp2-ATXN1[30Q]D776 mice.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26948890      PMCID: PMC4795980          DOI: 10.1016/j.neuron.2016.02.011

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


  61 in total

1.  Genome-wide atlas of gene expression in the adult mouse brain.

Authors:  Ed S Lein; Michael J Hawrylycz; Nancy Ao; Mikael Ayres; Amy Bensinger; Amy Bernard; Andrew F Boe; Mark S Boguski; Kevin S Brockway; Emi J Byrnes; Lin Chen; Li Chen; Tsuey-Ming Chen; Mei Chi Chin; Jimmy Chong; Brian E Crook; Aneta Czaplinska; Chinh N Dang; Suvro Datta; Nick R Dee; Aimee L Desaki; Tsega Desta; Ellen Diep; Tim A Dolbeare; Matthew J Donelan; Hong-Wei Dong; Jennifer G Dougherty; Ben J Duncan; Amanda J Ebbert; Gregor Eichele; Lili K Estin; Casey Faber; Benjamin A Facer; Rick Fields; Shanna R Fischer; Tim P Fliss; Cliff Frensley; Sabrina N Gates; Katie J Glattfelder; Kevin R Halverson; Matthew R Hart; John G Hohmann; Maureen P Howell; Darren P Jeung; Rebecca A Johnson; Patrick T Karr; Reena Kawal; Jolene M Kidney; Rachel H Knapik; Chihchau L Kuan; James H Lake; Annabel R Laramee; Kirk D Larsen; Christopher Lau; Tracy A Lemon; Agnes J Liang; Ying Liu; Lon T Luong; Jesse Michaels; Judith J Morgan; Rebecca J Morgan; Marty T Mortrud; Nerick F Mosqueda; Lydia L Ng; Randy Ng; Geralyn J Orta; Caroline C Overly; Tu H Pak; Sheana E Parry; Sayan D Pathak; Owen C Pearson; Ralph B Puchalski; Zackery L Riley; Hannah R Rockett; Stephen A Rowland; Joshua J Royall; Marcos J Ruiz; Nadia R Sarno; Katherine Schaffnit; Nadiya V Shapovalova; Taz Sivisay; Clifford R Slaughterbeck; Simon C Smith; Kimberly A Smith; Bryan I Smith; Andy J Sodt; Nick N Stewart; Kenda-Ruth Stumpf; Susan M Sunkin; Madhavi Sutram; Angelene Tam; Carey D Teemer; Christina Thaller; Carol L Thompson; Lee R Varnam; Axel Visel; Ray M Whitlock; Paul E Wohnoutka; Crissa K Wolkey; Victoria Y Wong; Matthew Wood; Murat B Yaylaoglu; Rob C Young; Brian L Youngstrom; Xu Feng Yuan; Bin Zhang; Theresa A Zwingman; Allan R Jones
Journal:  Nature       Date:  2006-12-06       Impact factor: 49.962

2.  Mutation of senataxin alters disease-specific transcriptional networks in patients with ataxia with oculomotor apraxia type 2.

Authors:  Brent L Fogel; Ellen Cho; Amanda Wahnich; Fuying Gao; Olivier J Becherel; Xizhe Wang; Francesca Fike; Leslie Chen; Chiara Criscuolo; Giuseppe De Michele; Alessandro Filla; Abigail Collins; Angelika F Hahn; Richard A Gatti; Genevieve Konopka; Susan Perlman; Martin F Lavin; Daniel H Geschwind; Giovanni Coppola
Journal:  Hum Mol Genet       Date:  2014-04-23       Impact factor: 6.150

3.  Murine prenatal expression of cholecystokinin in neural crest, enteric neurons, and enteroendocrine cells.

Authors:  J M Lay; P J Gillespie; L C Samuelson
Journal:  Dev Dyn       Date:  1999-10       Impact factor: 3.780

4.  Alternate drug delivery routes for A-71623, a potent cholecystokinin-A receptor agonist tetrapeptide.

Authors:  J B Cannon; L A Adjei; M Y Lu; K Garren
Journal:  J Drug Target       Date:  1996       Impact factor: 5.121

5.  Identification of candidate Purkinje cell-specific markers by gene expression profiling in wild-type and pcd(3J) mice.

Authors:  Yongqi Rong; Taiyu Wang; James I Morgan
Journal:  Brain Res Mol Brain Res       Date:  2004-12-20

6.  SCA1 transgenic mice: a model for neurodegeneration caused by an expanded CAG trinucleotide repeat.

Authors:  E N Burright; H B Clark; A Servadio; T Matilla; R M Feddersen; W S Yunis; L A Duvick; H Y Zoghbi; H T Orr
Journal:  Cell       Date:  1995-09-22       Impact factor: 41.582

7.  Neuropeptide Y mitigates neuropathology and motor deficits in mouse models of Machado-Joseph disease.

Authors:  Joana Duarte-Neves; Nélio Gonçalves; Janete Cunha-Santos; Ana Teresa Simões; Wilfred F A den Dunnen; Hirokazu Hirai; Sebastian Kügler; Cláudia Cavadas; Luís Pereira de Almeida
Journal:  Hum Mol Genet       Date:  2015-07-27       Impact factor: 6.150

8.  Mice lacking ataxin-1 display learning deficits and decreased hippocampal paired-pulse facilitation.

Authors:  A Matilla; E D Roberson; S Banfi; J Morales; D L Armstrong; E N Burright; H T Orr; J D Sweatt; H Y Zoghbi; M M Matzuk
Journal:  J Neurosci       Date:  1998-07-15       Impact factor: 6.167

9.  Phosphorylation of ATXN1 at Ser776 in the cerebellum.

Authors:  Nathan D Jorgensen; J Michael Andresen; Sara Lagalwar; Ben Armstrong; Sam Stevens; Courtney E Byam; Lisa A Duvick; Shaojuan Lai; Paymaan Jafar-Nejad; Huda Y Zoghbi; H Brent Clark; Harry T Orr
Journal:  J Neurochem       Date:  2009-05-15       Impact factor: 5.372

10.  A homozygous mutation in human PRICKLE1 causes an autosomal-recessive progressive myoclonus epilepsy-ataxia syndrome.

Authors:  Alexander G Bassuk; Robyn H Wallace; Aimee Buhr; Andrew R Buller; Zaid Afawi; Masahito Shimojo; Shingo Miyata; Shan Chen; Pedro Gonzalez-Alegre; Hilary L Griesbach; Shu Wu; Marcus Nashelsky; Eszter K Vladar; Dragana Antic; Polly J Ferguson; Sebahattin Cirak; Thomas Voit; Matthew P Scott; Jeffrey D Axelrod; Christina Gurnett; Azhar S Daoud; Sara Kivity; Miriam Y Neufeld; Aziz Mazarib; Rachel Straussberg; Simri Walid; Amos D Korczyn; Diane C Slusarski; Samuel F Berkovic; Hatem I El-Shanti
Journal:  Am J Hum Genet       Date:  2008-10-30       Impact factor: 11.025

View more
  49 in total

1.  MTSS1/Src family kinase dysregulation underlies multiple inherited ataxias.

Authors:  Alexander S Brown; Pratap Meera; Banu Altindag; Ravi Chopra; Emma M Perkins; Sharan Paul; Daniel R Scoles; Eric Tarapore; Jessica Magri; Haoran Huang; Mandy Jackson; Vikram G Shakkottai; Thomas S Otis; Stefan M Pulst; Scott X Atwood; Anthony E Oro
Journal:  Proc Natl Acad Sci U S A       Date:  2018-12-07       Impact factor: 11.205

2.  α1ACT Is Essential for Survival and Early Cerebellar Programming in a Critical Neonatal Window.

Authors:  Xiaofei Du; Cenfu Wei; Daniel Parviz Hejazi Pastor; Eshaan R Rao; Yan Li; Giorgio Grasselli; Jack Godfrey; Ann C Palmenberg; Jorge Andrade; Christian Hansel; Christopher M Gomez
Journal:  Neuron       Date:  2019-03-25       Impact factor: 17.173

3.  Nicotinamide Pathway-Dependent Sirt1 Activation Restores Calcium Homeostasis to Achieve Neuroprotection in Spinocerebellar Ataxia Type 7.

Authors:  Colleen A Stoyas; David D Bushart; Pawel M Switonski; Jacqueline M Ward; Akshay Alaghatta; Mi-Bo Tang; Chenchen Niu; Mandheer Wadhwa; Haoran Huang; Alex Savchenko; Karim Gariani; Fang Xie; Joseph R Delaney; Terry Gaasterland; Johan Auwerx; Vikram G Shakkottai; Albert R La Spada
Journal:  Neuron       Date:  2019-12-16       Impact factor: 17.173

Review 4.  Ion channel dysfunction in cerebellar ataxia.

Authors:  David D Bushart; Vikram G Shakkottai
Journal:  Neurosci Lett       Date:  2018-02-05       Impact factor: 3.046

5.  Cerebellar Regional Dissection for Molecular Analysis.

Authors:  Katherine A Hamel; Marija Cvetanovic
Journal:  J Vis Exp       Date:  2020-12-05       Impact factor: 1.355

6.  ATXN1-CIC Complex Is the Primary Driver of Cerebellar Pathology in Spinocerebellar Ataxia Type 1 through a Gain-of-Function Mechanism.

Authors:  Maxime W C Rousseaux; Tyler Tschumperlin; Hsiang-Chih Lu; Elizabeth P Lackey; Vitaliy V Bondar; Ying-Wooi Wan; Qiumin Tan; Carolyn J Adamski; Jillian Friedrich; Kirk Twaroski; Weili Chen; Jakub Tolar; Christine Henzler; Ajay Sharma; Aleksandar Bajić; Tao Lin; Lisa Duvick; Zhandong Liu; Roy V Sillitoe; Huda Y Zoghbi; Harry T Orr
Journal:  Neuron       Date:  2018-03-08       Impact factor: 17.173

7.  Mutant ataxin1 disrupts cerebellar development in spinocerebellar ataxia type 1.

Authors:  Chandrakanth Reddy Edamakanti; Jeehaeh Do; Alessandro Didonna; Marco Martina; Puneet Opal
Journal:  J Clin Invest       Date:  2018-04-23       Impact factor: 14.808

8.  Gene co-expression network analysis for identifying modules and functionally enriched pathways in SCA2.

Authors:  Lance T Pflieger; Warunee Dansithong; Sharan Paul; Daniel R Scoles; Karla P Figueroa; Pratap Meera; Thomas S Otis; Julio C Facelli; Stefan M Pulst
Journal:  Hum Mol Genet       Date:  2017-08-15       Impact factor: 6.150

9.  Reduction of protein kinase A-mediated phosphorylation of ATXN1-S776 in Purkinje cells delays onset of Ataxia in a SCA1 mouse model.

Authors:  Judit M Pérez Ortiz; Nissa Mollema; Nicholas Toker; Carolyn J Adamski; Brennon O'Callaghan; Lisa Duvick; Jillian Friedrich; Michael A Walters; Jessica Strasser; Jon E Hawkinson; Huda Y Zoghbi; Christine Henzler; Harry T Orr; Sarita Lagalwar
Journal:  Neurobiol Dis       Date:  2018-05-11       Impact factor: 5.996

Review 10.  Polyglutamine spinocerebellar ataxias - from genes to potential treatments.

Authors:  Henry L Paulson; Vikram G Shakkottai; H Brent Clark; Harry T Orr
Journal:  Nat Rev Neurosci       Date:  2017-08-17       Impact factor: 34.870

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.